Cargando…
The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial
BACKGROUND: Patient-reported outcomes (PROs) are getting widely implemented, but little is known of the impact of applying PROs in specific cancer diagnoses. We report the results of a randomized controlled trial (RCT) of the active use of PROs in patients with locally advanced or metastatic bladder...
Autores principales: | Taarnhøj, Gry Assam, Johansen, Christoffer, Carus, Andreas, Dahlrot, Rikke Hedegaard, Dohn, Line Hammer, Hjøllund, Niels Henrik, Knudsen, Mark Bech, Tolver, Anders, Lindberg, Henriette, Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562329/ https://www.ncbi.nlm.nih.gov/pubmed/37812306 http://dx.doi.org/10.1186/s41687-023-00640-5 |
Ejemplares similares
-
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
por: Taarnhøj, Gry Assam, et al.
Publicado: (2020) -
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
por: Taarnhøj, Gry Assam, et al.
Publicado: (2019) -
Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience
por: Taarnhøj, Gry Assam, et al.
Publicado: (2021) -
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
por: Taarnhøj, Gry A., et al.
Publicado: (2020) -
Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)